Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults

Tropical Medicine and International Health

Volumn 11, Issue 5, 2006, Pages 589-596

  Fanello, Caterina I ^a,c   Karema, Corine ^b   Van Doren, Walli ^d   Rwagacondo, Claude E ^b   D'Alessandro, Umberto ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b National Malaria Control Program   (Rwanda)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d Belgian Technical Cooperation   (Rwanda)

Author keywords

Amodiaquine; Plasmodium falciparum malaria; Rwanda; Sulphadoxine pyrimethamine; Tolerability

Indexed keywords

AMODIAQUINE; FANSIDAR;

DRUG RESISTANCE; MALARIA; MEDICINE; PARASITE RESISTANCE;

ABDOMINAL PAIN; ANOREXIA; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSPHAGIA; DYSURIA; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NAUSEA; NONHUMAN; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RWANDA; SIDE EFFECT; TINNITUS; TREATMENT OUTCOME; VOMITING;

ADULT; AMODIAQUINE; ANTIMALARIALS; BLOOD CELL COUNT; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FATIGUE; FEMALE; HEMATOCRIT; HUMANS; MALARIA, FALCIPARUM; MALE; NEUTROPENIA; PRURITUS; PYRIMETHAMINE; RWANDA; SULFADOXINE; TREATMENT OUTCOME;

AFRICA; CENTRAL AFRICA; RWANDA; SUB-SAHARAN AFRICA;

PLASMODIUM FALCIPARUM;

EID: 33646248912     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2006.01610.x     Document Type: Article

References (21)

1. Basco LK Same-Ekobo A Ngane VF et al. 2002 Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon Bulletin of the World Health Organization 80 538 545
2. Clark JB Maggs JL Kitteringham NR Park BK 1990 Immunogenicity of amodiaquine in the rat Int Arch Allergy Appl Immunol 91 335 342
3. Estes ML Ewing-Wilson D Chou SM et al. 1987 Chloroquine neuromyotoxicity. Clinical and pathologic perspective American Journal of Medicine 82 447 455
4. Harrison AC Kitteringham NR Clark JB Park BK 1992 The mechanism of bioactivation and antigen formation of amodiaquine in the rat Biochemical Pharmacology 43 1421 1430
5. Hatton CS Peto TE Bunch C et al. 1986 Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria Lancet 1 411 414
6. MacLehose HG Klaes D Garner P 2003 Amodiaquine: A Systematic Review of Adverse Events
7. Maggs JL Tingle MD Kitteringham NR Park BK 1988 Mechanisms of formation of protein to arylamines intermediaries from amodiaquine, a myelotoxin and hepatotoxin in man Biochemical Pharmacology 37 305 311
8. Neftel K Woodtly W Schimd M Frick PG Fehr J 1986 Amodiaquine induced agranulocytosis and liver damage British Medical Journal 292 721 723
9. Oduro AR Anyorigiya T Hodgson A et al. 2005 A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana Tropical Medicine and International Health 10 279 284
10. Olliaro P Mussano P 2003 Amodiaquine for treating malaria Cochrane Database of Systematic Reviews 2 CD000016
11. Olliaro P Nevill C LeBras J et al. 1996 Systematic review of amodiaquine treatment in uncomplicated malaria Lancet 348 1196 1201
12. Phillips-Howard PA West LJ 1990 Serious adverse drug reactions to pyrmethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain Journal of the Royal Society of Medicine 83 82 84
13. Rwagacondo CE Niyitegeka F Sarushi J et al. 2003 Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate American Journal of Tropical Medicine and Hygiene 68 743 747
14. Rwagacondo CE Karema C Mugisha V et al. 2004 Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria Tropical Medicine and International Health 9 1091 1098
15. Staedke SG Kamya MR Dorsey G et al. 2001 Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial Lancet 358 368 374
16. WHO 1996 Management of Uncomplicated Malaria and the Use of Antimalarial Drugs for the Protection of Travellers: Report of an Informal Consultation WHO Geneva
17. WHO 2002a Report of the WHO Expert Committee on the Selection and Use of Essential Medicines WHO Geneva 15-19 April 2002
18. WHO 2002b Monitoring Antimalarial Drug Resistance World Health Organization Geneva pp 1 31
19. WHO 2003a Report of the WHO Expert Committee on the Selection and Use of Essential Medicines WHO Geneva
20. WHO 2003b Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria World Health Organization Geneva
21. Yeka A Banek K Bakyaita N et al. 2005 Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda PLoS Medicine 2 e190